TrialClinical and vaccine immunology : CVI2011

Long-term immunogenicity after one and two doses of a monovalent MF59-adjuvanted A/H1N1 Influenza virus vaccine coadministered with the seasonal 2009-2010 nonadjuvanted Influenza virus vaccine in HIV-infected children, adolescents, and young adults in a randomized controlled trial.

Alessandra Viganò et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.